About: Good clinical practice advice for the management of patients with gynaecological cancer during the COVID-19 pandemic in Nigeria and other resource-constrained countries

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Good clinical practice advice for the management of patients with gynaecological cancer during the COVID-19 pandemic in Nigeria and other resource-constrained countries Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Good clinical practice advice for the management of patients with gynaecological cancer during the COVID-19 pandemic in Nigeria and other resource-constrained countries
Creator	Okunade, Kehinde Anorlu, Rose Ohazurike, Ephraim Okunowo, Adeyemi
source	PMC
abstract	The impact of the COVID-19 pandemic on healthcare services in settings with under-resourced health systems such as that of Nigeria is likely to be substantial in the coming months. The gynaecological oncology services still need to be prioritised as an essential core health service. There are increasing concerns from both physicians and patients regarding how to manage patients diagnosed with cancer during this pandemic as evidence suggests a substantial increase in the risk of COVID-19-related deaths amongst patients with cancer. However, we recognise that despite this great challenge, we must continue to provide the highest quality of care to the patients, whereas, at the same time, ensure adequate safety not only for the patients and their families but also for the entire oncology team. We advocate that due to the widespread travel restrictions and inability to refer patients for the highest level of care at this period, centres without radiotherapy facilities as seen in most resource-limited settings should always consider lower level care options such as the use of chemotherapy pending when there is a better access to these facilities. We, therefore, developed this good clinical practice advice to staff of the gynaecological oncology unit in the centre and other resource-constrained settings for the management of patients with gynaecological cancer during the COVID-19 pandemic.
has issue date	2020-07-17(xsd:dateTime)
bibo:doi	10.3332/ecancer.2020.1075
bibo:pmid	32863869
has license	cc-by
sha1sum (hex)	14fec46163221f9fe3e28f2ac1791cc099ea5546
schema:url	https://doi.org/10.3332/ecancer.2020.1075
resource representing a document's title	Good clinical practice advice for the management of patients with gynaecological cancer during the COVID-19 pandemic in Nigeria and other resource-constrained countries
has PubMed Central identifier	PMC7434503
has PubMed identifier	32863869
schema:publication	Ecancermedicalscience
resource representing a document's body	covid:14fec46163221f9fe3e28f2ac1791cc099ea5546#body_text
is schema:about of	named entity 'gynaecological cancer' named entity 'physicians' named entity 'MANAGEMENT' named entity 'NEED' named entity 'REFER' named entity 'ONCOLOGY UNIT' named entity 'CHEMOTHERAPY' named entity 'QUALITY OF CARE' covid:arg/14fec46163221f9fe3e28f2ac1791cc099ea5546 named entity 'facilities' named entity 'patients' named entity 'restrictions' named entity 'services' named entity 'families' named entity 'gynaecological' named entity 'oncology' named entity 'care' named entity 'unit' named entity 'health service' named entity 'COVID-19' named entity 'quality of care' named entity 'oncology unit' named entity 'good clinical practice' named entity 'health systems' named entity 'Nigeria' named entity 'COVID-19' named entity 'gynaecological' named entity 'physical distancing' named entity 'gynaecological cancer' named entity 'omentectomy' named entity 'neoadjuvant therapy' named entity 'personal protective equipment (PPE' named entity 'gynaecological' named entity 'COVID-19' named entity 'radiotherapy' named entity 'surgical management' named entity 'surgical mask' named entity 'adjuvant treatment' named entity 'co-morbidities' named entity 'radiotherapy' named entity 'infection' named entity 'World Health Organisation' named entity 'follow-up' named entity 'gynaecological' named entity 'palliative therapy' named entity 'neoadjuvant chemotherapy' named entity 'morbidity' named entity 'histology' named entity 'symptomatic management' named entity 'taking steps' named entity 'COVID-19' named entity 'gynaecological cancer' named entity 'COVID-19' named entity 'ambulatory care' named entity 'infection' named entity 'cytoreduction' named entity 'COVID-19' named entity 'radiotherapy' named entity 'systemic therapy' named entity 'COVID-19' named entity 'Public Health Emergency of International Concern' named entity 'PPE' named entity 'social isolation' named entity 'ovarian cancer' named entity 'uterine sarcoma' named entity 'laparotomy' named entity 'PPE' named entity 'chemotherapy' named entity 'levonorgestrel' named entity 'COVID-19 pandemic' named entity 'oncology' named entity 'systemic therapy' named entity 'COVID-19' named entity 'PPE' named entity 'infection' named entity 'COVID-19' named entity 'chemotherapy' named entity 'antibiotics'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software